Inscinstech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Investors
  • 12

Inscinstech General Information

Description

Developer of biological separation technology for biopharmaceutical CMCs. The company aims to develop environmental monitoring devices and equipment used in bio labs, providing clients with quick chemical analysis and high quality data while reducing lab costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 101, Building 13, No. 998, Pangnan Road
  • Jiangling Street, Wujiang District
  • Suzhou, Jiangsu 215200
  • China
+86 0512
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Building 101, Building 13, No. 998, Pangnan Road
  • Jiangling Street, Wujiang District
  • Suzhou, Jiangsu 215200
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inscinstech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 21-Jan-2025 Completed Generating Revenue
6. Later Stage VC 19-Aug-2024 Completed Generating Revenue
5. Later Stage VC (Series B1) 10-Jan-2023 Completed Generating Revenue
4. Later Stage VC (Series B) 18-Nov-2022 Completed Generating Revenue
3. Early Stage VC (Series A1) 07-Feb-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Oct-2021 $10M $11.5M Completed Generating Revenue
1. Early Stage VC 26-Jan-2021 $1.54M $1.54M Completed Generating Revenue
To view Inscinstech’s complete valuation and funding history, request access »

Inscinstech Patents

Inscinstech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260208144-A1 Method and apparatus for synthesis reaction between reagent and packing Pending 22-Jan-2025
WO-2026157194-A1 Method for causing synthesis reaction between reagent and packing material, and device Pending 22-Jan-2025
US-20260185617-A1 Selection valve Pending 02-Jan-2025
EP-4800274-A1 Selector valve Pending 02-Jan-2025
WO-2026144377-A1 Selector valve Pending 02-Jan-2025 F16K11/0743
To view Inscinstech’s complete patent history, request access »

Inscinstech Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Merchants Capital Asset Manager Minority
Suzhou Oriza Holdings Corporation Asset Manager Minority
China Merchants Kunlun Capital Growth/Expansion Minority
Qiming Venture Partners Venture Capital Minority
Huaxin Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Inscinstech Investments (1)

Inscinstech’s most recent deal was a Early Stage VC with Xingchen Zhiyao. The deal was made on 17-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xingchen Zhiyao 17-Mar-2023 Early Stage VC Drug Discovery
To view Inscinstech’s complete investments history, request access »

Inscinstech FAQs

  • When was Inscinstech founded?

    Inscinstech was founded in 2017.

  • Where is Inscinstech headquartered?

    Inscinstech is headquartered in Suzhou, China.

  • What industry is Inscinstech in?

    Inscinstech’s primary industry is Other Devices and Supplies.

  • Is Inscinstech a private or public company?

    Inscinstech is a Private company.

  • What is Inscinstech’s current revenue?

    The current revenue for Inscinstech is .

  • How much funding has Inscinstech raised over time?

    Inscinstech has raised $11.5M.

  • Who are Inscinstech’s investors?

    China Merchants Capital, Suzhou Oriza Holdings Corporation, China Merchants Kunlun Capital, Qiming Venture Partners, and Huaxin Capital are 5 of 12 investors who have invested in Inscinstech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process